This report, the first-of-its-kind, based on extensive desk and field research in four Indian states - Maharashtra, Karnataka, Gujarat and Telangana - and seven countries - USA, UK, Switzerland, Germany, South Africa, Singapore and Indonesia - incorporates the views of more than 150 stakeholders to identify lessons as well as opportunities address challenges of drug regulation in India.